|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,630.00 KRW | +0.83% |
|
+10.67% | -47.24% |
| 04-13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-02 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Quotes 5-day view: Genome & Company
End-of-day quote Korea S.E.| 03/08/2026 | 04/08/2026 | 05/08/2026 | 06/08/2026 | 07/08/2026 | |
|---|---|---|---|---|---|
| Last | ₩3,455.00 | ₩3,650.00 | ₩3,580.00 | ₩3,600.00 | ₩3,630.00 |
| Volume | 323,748 | 479,996 | 480,370 | 381,531 | 471,416 |
| Change | +5.34% | +5.64% | -1.92% | +0.56% | +0.83% |
| Opening | ₩3,115.00 | ₩3,365.00 | ₩3,735.00 | ₩3,520.00 | ₩3,585.00 |
| High | ₩3,625.00 | ₩4,050.00 | ₩3,875.00 | ₩3,680.00 | ₩3,635.00 |
| Low | ₩3,115.00 | ₩3,365.00 | ₩3,530.00 | ₩3,400.00 | ₩3,365.00 |
Performance
| 1 day | +0.83% | ||
| 1 week | +10.67% | ||
| Current month | +10.67% | ||
| 1 month | +3.86% | ||
| 3 months | -46.62% | ||
| 6 months | -51.92% | ||
| Current year | -47.24% | ||
| 1 year | +38.81% | ||
| 3 years | -46.89% | ||
| 5 years | -79.83% |
Volumes
marketsDaily volume
471,416
Avg. Volume 20 sessions
389,953
Avg. Volume 20 sessions KRW
1,415,529,390
Avg. Volume 20 sessions USD
999,363.75
Record volume 1
30,576,260
Record volume 2
14,495,024
Record volume 3
7,918,904
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (KRW)
164,797,256,248
Market Cap (USD)
116,923,095
Net sales ()
24,586,847,080
Net sales (USD)
17,444,285
Free-Float
82.88 %
Free-Float capitalization (KRW)
136,581,356,885
Free-Float capitalization (USD)
96,904,010
Average Daily Capital Traded
0.86%
Indicators
Moving average 5 days
3,583
Moving average 20 days
3,631.75
Moving average 50 days
4,323.9
Moving average 100 days
5,798.25
Price spread / (MMA5)
-1.29%
Price spread / (MMA20)
+0.05%
Price spread / (MMA50)
+19.12%
Price spread / (MMA100)
+59.73%
RSI 9 days
50.45
RSI 14 days
46.84
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.83% | +10.67% | +38.81% | -46.89% | 117M | |
| +0.99% | +1.78% | +5.07% | +16.49% | 49.47B | |
| +3.71% | +9.40% | +486.14% | +579.98% | 43.97B | |
| +5.60% | +10.21% | +20.85% | +81.78% | 39.6B | |
| +2.70% | +1.57% | +32.71% | +9.07% | 39.29B | |
| +2.21% | +6.75% | +20.20% | +54.40% | 32.43B | |
| +2.23% | +4.71% | - | - | 16.84B | |
| +0.97% | +2.35% | +35.99% | +124.45% | 16.49B | |
| -0.11% | +2.41% | +5.03% | +20.47% | 14.01B | |
| +0.75% | +15.04% | +79.84% | +29.70% | 12.77B | |
| Average | +1.99% | +6.19% | +80.52% | +96.61% | 26.5B | |
| Weighted average by Cap. | +2.54% | +6.10% | +105.10% | +138.59% |
Historical Quotes: Genome & Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 3,115 |  | 4,050 |
| 1 month | 2,975 | | 4,545 |
| Current year | 2,975 | | 10,180 |
| 1 year | 2,440 | | 10,180 |
| 3 years | 2,170 | | 10,180 |
| 5 years | 2,170 | | 28,800 |
| 10 years | 2,170 | | 47,500 |
Monthly variations
Annual variations
| 2026 | -47.24% | ||
| 2025 | +150.18% | ||
| 2024 | -55.96% | ||
| 2023 | -28.42% | ||
| 2022 | -49.71% | ||
| 2021 | -56.35% | ||
| 2020 | +102.29% | ||
| 2019 | +219.51% | ||
| 2018 | +31.83% |
- Stock Market
- Stocks
- A314130 Stock
- Quotes Genome & Company
Select your edition
All financial news and data tailored to specific country editions
